| Aliivibrio fischeri |
Transcriptional activator protein luxR |
Activity |
nan |
None |
10.1016/j.bmcl.2010.06.081 |
| Aliivibrio fischeri |
Transcriptional activator protein luxR |
IC50 |
91000.0 |
nM |
10.1016/j.bmcl.2010.06.081 |
| Bos taurus |
Calmodulin |
EC50 |
2100.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| Bos taurus |
Calmodulin |
Kd |
500.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| Bos taurus |
Calmodulin |
Kd |
2900.0 |
nM |
10.1016/j.ejmech.2016.03.045 |
| Cavia porcellus |
Voltage-dependent L-type calcium channel subunit alpha-1C |
IC50 |
17000.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
26791.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
25791.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
5894.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BXPC-3 |
IC50 |
28600.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Caco-2 |
IC50 |
14500.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Calcium sensing receptor |
EC50 |
1000.0 |
nM |
10.1016/j.bmcl.2013.01.078 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
5.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
21731.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
9870.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
3482.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEC-1-A |
IC50 |
9480.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
HEC-1B cell line |
IC50 |
9800.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
HERG |
AC50 |
1300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-35.48 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
4.2 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Ishikawa |
IC50 |
30000.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
MIA PaCa-2 |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
MIA PaCa-2 |
IC50 |
9200.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
720.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
780.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
26734.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
6172.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NCI-H1299 |
IC50 |
24300.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
NCI-H1975 |
IC50 |
30000.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
NCI-H23 |
IC50 |
11400.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
NCI-H522 |
IC50 |
29600.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
3260.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
14946.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
3217.0 |
nM |
10.1021/jm100600y |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
10.1021/jm2011657 |
| Homo sapiens |
Serotonin transporter |
AC50 |
7935.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SK-CO-1 |
IC50 |
7800.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
15.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
20.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
-118.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Activity |
25.2 |
% |
10.1021/jm070524a |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
IC50 |
5600.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Inhibition |
nan |
% |
10.1016/j.ejmech.2021.113381 |
| Homo sapiens |
Thrombin |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
20689.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
MEF |
IC50 |
8100.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Mus musculus |
MEF |
IC50 |
13100.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Mus musculus |
MEF |
IC50 |
17800.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.22 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.24 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
86.5 |
% |
10.21203/rs.3.rs-23951/v1 |
| None |
ADMET |
LC50 |
4330.0 |
nM |
10.1016/j.bmc.2013.09.022 |
| None |
ADMET |
PPB |
98.84 |
% |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
4.89 |
None |
10.1021/jm070524a |
| None |
No relevant target |
pKa |
9.04 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
9.04 |
None |
10.1016/j.ejmech.2016.03.045 |
| None |
No relevant target |
pKa |
9.04 |
None |
10.1021/jm070524a |
| None |
No relevant target |
pKa |
9.3 |
None |
10.1007/s11095-013-1232-z |
| None |
Unchecked |
Ac50 |
1.995 |
uM |
None |
| None |
Unchecked |
Ac50 |
2.512 |
uM |
None |
| None |
Unchecked |
Ac50 |
6.108 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
Ac50 |
43.24 |
uM |
None |
| None |
Unchecked |
AC50 |
1995.3 |
nM |
None |
| None |
Unchecked |
AC50 |
2511.9 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
EC50 |
4350.0 |
nM |
10.1016/j.bmc.2013.09.022 |
| None |
Unchecked |
IC50 |
10800.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| None |
Unchecked |
IC50 |
11100.0 |
nM |
10.1016/j.ejmech.2021.113381 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2021.113381 |
| None |
Unchecked |
Ratio |
0.99 |
None |
10.1016/j.bmc.2013.09.022 |